Use of Hydroxychloroquine in Hair Disorders

    January 2023 in “ Skin Appendage Disorders
    Advaitaa Ravipati, Michael Randolph, Waleed Alsalhi, Antonellá Tosti
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Studysummary This review summarizes existing literature on hydroxychloroquine for treating autoimmune-related hair disorders, highlighting its variable efficacy and emphasizing the need for individualized treatment decisions, but reports no new clinical results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Hydroxychloroquine (HCQ) was used to treat hair disorders with autoimmune components such as lichen planopilaris (LPP), frontal fibrosing alopecia (FFA), and alopecia areata (AA). The literature indicated variable efficacy, with some patients experiencing halted hair loss while others saw no improvement. Treatment regimens varied from HCQ monotherapy to combinations with other agents like steroids. Despite the lack of standardized treatment guidelines, HCQ was recommended as a potential option for these conditions, with decisions tailored to individual patient characteristics and clinical judgment, considering the risks of side effects.
    Discuss this study in the Community →

    Research cited in this study

    34 / 34 results